Personal information

Emails & domains

Verified email domains

Other IDs

ResearcherID: H-1908-2014

Keywords

Cancer biology, EMT, MDM2

Countries

Czech Republic

Activities

Collapse all

Employment (3)

St. Anne's University Hospital: Brno, CZ

Research technician (ICRC)
Employment
Source: Self-asserted source
Eva Slabakova

Institute of Biophysics AS CR, v.v.i.: Brno, CZ

Postdoc (Dept. of Cytokinetics)
Employment
Source: Self-asserted source
Eva Slabakova

Masaryk University: Brno, CZ

2023-01-01 to present | Project Coordinator (Department of Experimental Biology)
Employment
Source: Self-asserted source
Eva Slabakova

Education and qualifications (1)

Masaryk University: Brno, CZ

Ph.D.
Education
Source: Self-asserted source
Eva Slabakova

Funding (1)

The role of MDM2 in epithelial-to-mesenchymal transition: implication for cancer progression

2012-01 to 2014 | Grant
Grant Agency of the Czech Republic (Prague, CZ)
Source: Self-asserted source
Eva Slabakova

Works (13)

Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis

The American Journal of Pathology
2022-09 | Journal article
DOI: 10.1016/j.ajpath.2022.05.009
Contributors: Ximena M. Muresan; Eva Slabáková; Jiřina Procházková; Stanislav Drápela; Radek Fedr; Markéta Pícková; Ondřej Vacek; Ráchel Víchová; Tereza Suchánková; Jan Bouchal et al.
Source: check_circle
Crossref

Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs

Non-Coding RNA
2021-12 | Journal article | Author
DOI: 10.3390/ncrna7040075
Contributors: Eva Slabakova; Zuzana Kahounová; Jiřina Procházková; Karel Soucek
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.

2014-05 | Journal article
DOI:

10.1186/1476-4598-13-113

PMID:

24884804
Contributors: Pernicová Z; Slabáková E; Fedr R; Ime Ková A; Jaro J; Suchánková T; Bouchal J; Kharaishvili G; Král M; Kozubík A et al.
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.

2013-05 | Journal article
DOI:

10.1002/cyto.a.22273

PMID:

23450810
Contributors: Fedr R; Pernicová Z; Slabáková E; Straková N; Bouchal J; Grepl M; Kozubík A; Souček K
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy.

2012 | Journal article
DOI:

10.1155/2012/980658

PMID:

23320042

PMC:

PMC3541534
Contributors: Torricelli C; Salvadori S; Valacchi G; Souček K; Slabáková E; Muscettola M; Volpi N; Maioli E
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

TGF-β1 signaling plays a dominant role in the crosstalk between TGF-β1 and the aryl hydrocarbon receptor ligand in prostate epithelial cells.

2012-08 | Journal article
DOI:

10.1016/j.cellsig.2012.04.008

PMID:

22560882
Contributors: Staršíchová A; Hrubá E; Slabáková E; Pernicová Z; Procházková J; Pěnčíková K; Seda V; Kabátková M; Vondráček J; Kozubík A et al.
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug.

2011-09 | Journal article
DOI:

10.1002/pros.21350

PMID:

21321977
Contributors: Slabáková E; Pernicová Z; Slavíčková E; Staršíchová A; Kozubík A; Souček K
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2.

2011-06 | Journal article
PMID:

21677876

PMC:

PMC3114246
Contributors: Pernicová Z; Slabáková E; Kharaishvili G; Bouchal J; Král M; Kunická Z; Machala M; Kozubík A; Souček K
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

Growth/differentiation factor-15 is an abundant cytokine in human seminal plasma.

2010-12 | Journal article
DOI:

10.1093/humrep/deq264

PMID:

20884666
Contributors: Soucek K; Slabáková E; Ovesná P; Malenovská A; Kozubík A; Hampl A
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells.

2010-11 | Journal article
DOI:

10.1016/j.cellsig.2010.06.014

PMID:

20603212
Contributors: Starsíchová A; Lincová E; Pernicová Z; Kozubík A; Soucek K
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

Dynamic Monitoring of Cellular Remodeling Induced by the Transforming Growth Factor-β1.

2009 | Journal article
DOI:

10.1007/s12575-009-9017-9

PMID:

19756912

PMC:

PMC3056018
Contributors: Staršíchová A; Kubala L; Lincová E; Pernicová Z; Kozubík A; Souček K
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.

2009-11 | Journal article
DOI:

10.1016/j.diff.2009.07.008

PMID:

19695766
Contributors: Vanhara P; Lincová E; Kozubík A; Jurdic P; Soucek K; Smarda J
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central

Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.

2009-09 | Journal article
DOI:

10.1016/j.bcp.2009.05.001

PMID:

19433066
Contributors: Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
Source: Self-asserted source
Eva Slabakova via Europe PubMed Central
How many people are using ORCID?